FDA Import Refusal AEK-9448937-2/20003/1 — ACME Formulation Private Limited
The FDA refused shipment AEK-9448937-2/20003/1 from ACME Formulation Private Limited (India) on February 21, 2026. The refused product falls under Drugs and Biologics — METFORMIN HCL (ANTI-DIABETIC). Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal Details
- Date
- February 21, 2026
- Country
- India
- Product Category
- Drugs and Biologics
- Product Code
- 61PDY55 METFORMIN HCL (ANTI-DIABETIC)
- Charges
- 75